vaccines in India, Zydus Cadila has started enrolling and dosing participants for its phase 3 trial to determine the efficacy of its covid-19 shot ZyCov-D, two officials in the know told Mint.“We started enrolment and dosing of participants from Saturday.
The enrolment and dosing happens between 9 am and 5 pm," the principal investigator at one of the sites said.Also Read | Why server stacks are the new realty playZydus Cadila plans to recruit 28,216 volunteers across five sites in four cities, according to information provided to the government’s clinical trial registry.
Read more on livemint.com